MyRNA Diagnostics is establishing Malaysia’s leading miRNA-based early cancer detection platform — localising globally validated technology to improve survival through earlier intervention.
A blood-based miRNA molecular screening test designed to identify individuals at elevated risk of gastric cancer and support earlier clinical intervention.
Learn More
A blood-based miRNA risk stratification test designed to identify individuals at increased risk of lung cancer and support earlier detection strategies.
Learn MoreWe collaborate with leading organizations to deliver exceptional solutions.
Stay informed with our latest articles, insights, and news.
On 4 August 2026, MyRNA Diagnostics hosted a Continuing Medical Education (CME) session at Hospital Canselor Tuanku Muhriz UKM (HCTM), bringing togeth...
From 28–30 August 2026, MyRNA participated in GUT 2026, the Annual Scientific Meeting of the Malaysian Society of Gastroenterology & Hepatology (M...
At MyRNA Diagnostics, we believe that meaningful healthcare innovation happens when science, clinical expertise and industry come together with a shar...
Let's discuss how we can help you achieve your goals with our innovative solutions.
Enquire About Partnership